ACTIVE

CRAYNWINKEL

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

35,7 k €

+200.9% YoY

Revenue

366 k €

+21.1% YoY

Equity

9,4 k €

+135.6% YoY

What does CRAYNWINKEL do?

CRAYNWINKEL is a Private company with limited liability incorporated in 2001. Its registered office is in Lubbeek.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0474.769.468

Incorporation

08/05/2001

Legal form

Private company with limited liability

Registered office

Staatsbaan(LUB) 187
3210 Lubbeek · FlandreSee on map

Contributed capital

176 000,00 €

Latest accounts

31/12/2025

Joint committees (1)

Contacts

4 public details availableLog in to view

Signals

ProfitablePositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Revenue	366 k €	+21.1%	302,4 k €	+7.1%	282,2 k €	-24.3%	372,9 k €	-55.2%	831,7 k €	-22.8%	1,1 M €	-25.8%	1,5 M €	+11.1%	1,3 M €	-0.3%	1,3 M €	-4.7%	1,4 M €	-12.9%	1,6 M €	+25.4%	1,3 M €	+67.2%	752,8 k €	-4.3%	786,4 k €	+1.1%	777,9 k €	-1.0%	785,4 k €	-22.5%	1 M €	-9.2%	1,1 M €	+17.3%	951,2 k €	-19.8%	1,2 M €
EBITDA	120,1 k €	+47.1%	81,7 k €	-2.6%	83,8 k €	-23.7%	109,9 k €	-21.3%	139,6 k €	-27.2%	191,9 k €	-9.3%	211,6 k €	+4.5%	202,6 k €	-15.9%	240,9 k €	+8.1%	222,8 k €	-21.1%	282,4 k €	+33.7%	211,2 k €	+24.6%	169,5 k €	-6.8%	181,9 k €	+23.9%	146,8 k €	+14.2%	128,5 k €	-34.0%	194,8 k €	+0.2%	194,4 k €	+39.6%	139,3 k €	-6.1%	148,4 k €
Operating result	54,1 k €	+108%	26 k €	+323%	-11,7 k €	-233%	8,8 k €	-41.2%	14,9 k €	-35.2%	23 k €	-20.9%	29,1 k €	+251%	8,3 k €	+185%	2,9 k €	-95.6%	66,6 k €	+12.7%	59,1 k €	+268%	16,1 k €	-60.5%	40,7 k €	-25.9%	54,9 k €	+103%	27 k €	+667%	-4,8 k €	-111%	45,1 k €	-23.9%	59,3 k €	+199%	19,8 k €	-26.6%	27 k €
Net result	35,7 k €	+201%	11,9 k €	+166%	-18 k €	-22.7%	-14,7 k €	-21.4%	-12,1 k €	+50.5%	-24,4 k €	-705%	4 k €	+115%	-27,2 k €	-25.6%	-21,7 k €	-168%	32 k €	+2384%	1,3 k €	+105%	-28,3 k €	-420%	8,8 k €	-2.2%	9 k €	+476%	1,6 k €	+105%	-31,6 k €	-1184%	2,9 k €	-82.5%	16,6 k €	+240%	4,9 k €	+43.9%	3,4 k €
Balance sheet
Equity	9,4 k €	+136%	-26,3 k €	+31.1%	-38,2 k €	-89.4%	-20,1 k €	-269%	-5,5 k €	-182%	6,6 k €	-78.6%	31 k €	+14.9%	27 k €	-50.2%	54,2 k €	-48.7%	105,7 k €	+43.4%	73,7 k €	+1.8%	72,4 k €	-28.1%	100,8 k €	+9.6%	91,9 k €	+10.9%	82,9 k €	+1.9%	81,3 k €	-28.0%	112,9 k €	+2.7%	110 k €	+17.8%	93,4 k €	+5.5%	88,5 k €
Total assets	1,8 M €	-1.9%	1,8 M €	-4.1%	1,9 M €	-1.1%	1,9 M €	+3.8%	1,8 M €	-15.4%	2,1 M €	-7.1%	2,3 M €	+8.2%	2,1 M €	-4.8%	2,2 M €	-9.2%	2,5 M €	-4.7%	2,6 M €	-2.2%	2,7 M €	+5.4%	2,5 M €	+55.6%	1,6 M €	+5.6%	1,5 M €	+4.7%	1,5 M €	+0.0%	1,5 M €	-7.9%	1,6 M €	+23.8%	1,3 M €	+5.1%	1,2 M €
Cash	2,7 k €		–		353 €	-75.1%	1,4 k €	+118%	651 €		0 €		0 €		0 €	-100%	13,8 k €	+25.6%	11 k €	-57.0%	25,5 k €	+34.9%	18,9 k €	+10.1%	17,1 k €	-55.7%	38,7 k €	-28.2%	53,9 k €	+44.6%	37,3 k €	+98.6%	18,8 k €	+113%	8,8 k €	+64.2%	5,4 k €	-11.5%	6,1 k €
Debts	1,7 M €	-3.8%	1,8 M €	-4.6%	1,9 M €	-0.2%	1,9 M €	+4.6%	1,8 M €	-14.9%	2,1 M €	-6.1%	2,3 M €	+8.2%	2,1 M €	-3.6%	2,2 M €	-7.5%	2,4 M €	-6.1%	2,5 M €	-2.4%	2,6 M €	+6.8%	2,4 M €	+58.4%	1,5 M €	+5.3%	1,4 M €	+4.8%	1,4 M €	+2.3%	1,4 M €	-8.7%	1,5 M €	+24.2%	1,2 M €	+5.5%	1,1 M €
Other
Workforce	–		–		–		–		–		–		–		–		–		–		6,5 ETP	+30.0%	5,0 ETP	+213%	1,6 ETP	-36.0%	2,5 ETP	-28.6%	3,5 ETP	+12.9%	3,1 ETP	+34.8%	2,3 ETP	+91.7%	1,2 ETP	-14.3%	1,4 ETP	-12.5%	1,6 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 3 ended

Active mandates

Carine Knapen

Mandate

Active

Theo Schrevens

Mandate

Active

Ended mandates

SCHREVENS - Beheer

Mandate · 0444.719.957

Represented by Teofiel Schrevens

Ended

SCHREVENS - Beheer

Mandate · 0444.719.957

Represented by Teofiel Schrevens

Ended

Teofiel Schrevens

Mandate

Ended

At this address

Other companies at this address

Company	CBE no.
Beisol Pharma Kortenberg● Active	0544.650.050
Beisol Pharma Lubbeek● Active	0773.648.838
Beisol Pharma Meerle● Active	0544.650.644
Beisol Pharma Merkplas● Active	0544.652.723
Beisol Pharma Neerijse● Active	0544.653.020
Beisol Pharma Poederlee● Active	0544.651.040
Beisol Pharma Tienen● Active	0544.648.961
KULAPRO● Active	0419.774.527

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	09/08/2026	01/10/2025	29/09/2024	09/10/2023	27/10/2022	30/10/2021
General meeting	30/07/2026	11/09/2025	05/09/2024	09/10/2023	01/09/2022	02/09/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	30/07/2026	09/08/2026	Dutch	PDF
Micro model	31/12/2024	11/09/2025	01/10/2025	Dutch	PDF
Micro model	31/12/2023	05/09/2024	29/09/2024	Dutch	PDF
Micro model	31/12/2022	09/10/2023	09/10/2023	Dutch	PDF
Micro model	31/12/2021	01/09/2022	27/10/2022	Dutch	PDF
Micro model	31/12/2020	02/09/2021	30/10/2021	Dutch	PDF
Abridged model	31/12/2019	28/08/2020	10/09/2020	Dutch	PDF
Abridged model	31/12/2018	27/06/2019	31/08/2019	Dutch	PDF
Abridged model	31/12/2017	28/06/2018	18/09/2018	Dutch	PDF
Abridged model	31/12/2016	29/06/2017	10/10/2017	Dutch	PDF
Abridged model	31/12/2015	26/06/2016	12/07/2016	Dutch	PDF
Abridged model	31/12/2014	30/07/2015	17/09/2015	Dutch	PDF
Abridged model	31/12/2013	31/07/2014	12/08/2014	Dutch	PDF
Abridged model	31/12/2012	08/08/2013	21/08/2013	Dutch	PDF
Abridged model	31/12/2011	06/09/2012	27/09/2012	Dutch	PDF
Abridged model	31/12/2010	09/09/2011	14/09/2011	Dutch	PDF
Abridged model	31/12/2009	25/06/2010	30/06/2010	Dutch	PDF
Abridged model	31/12/2008	11/09/2009	28/09/2009	Dutch	PDF
Abridged model	31/12/2007	06/06/2008	17/06/2008	Dutch	PDF
Abridged model	31/12/2006	31/05/2007	26/06/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 3 ended

Active mandates

Carine Knapen

Mandate

Active

Theo Schrevens

Mandate

Active

Ended mandates

SCHREVENS - Beheer

Mandate · 0444.719.957

Represented by Teofiel Schrevens

Ended

SCHREVENS - Beheer

Mandate · 0444.719.957

Represented by Teofiel Schrevens

Ended

Teofiel Schrevens

Mandate

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates06/03/2020
ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/12/2019
ONTSLAGEN - BENOEMINGEN
PDF
Mandates19/09/2016
DOEL - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Restructuring10/11/2014
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Restructuring04/11/2014
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Restructuring26/08/2014
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...) - DIVERSEN
PDF
Restructuring26/08/2014
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...) - DIVERSEN
PDF
Registered office08/06/2010
MAATSCHAPPELIJKE ZETEL
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202535,7 k €↑
2024
Annual accounts 202411,9 k €↑
2023
Annual accounts 2023-18 k €↓
2022
Annual accounts 2022-14,7 k €↓
2021
Annual accounts 2021-12,1 k €↑
2020
Annual accounts 2020-24,4 k €↓
2019
Annual accounts 20194 k €↑
2018
Annual accounts 2018-27,2 k €↓
2017
Annual accounts 2017-21,7 k €↓
2016
Annual accounts 201632 k €↑
2015
Annual accounts 20151,3 k €↑
2014
Annual accounts 2014-28,3 k €↓
2013
Annual accounts 20138,8 k €↓
2012
Annual accounts 20129 k €↑
2011
Annual accounts 20111,6 k €↑
2010
Annual accounts 2010-31,6 k €↓
2009
Annual accounts 20092,9 k €↓
2008
Annual accounts 200816,6 k €↑
2007
Annual accounts 20074,9 k €↑
2006
Annual accounts 20063,4 k €
08/05/2001
IncorporationPrivate company with limited liability

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

CRAYNWINKEL

Overview

What does CRAYNWINKEL do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline